Inventiva (IVA) Interest Expenses (2019 - 2025)

Inventiva's (IVA) quarterly Interest Expenses came in at -$130.7 million in Q2 2025, down 485455.24% year-on-year from N/an in Q2 2024, and down 489223.09% quarter-over-quarter from -$26714.9 in Q4 2024.

Inventiva (IVA) Interest Expenses (2019 - 2025) Analysis & Trends

Inventiva's Interest Expenses history runs 7 years deep, the most recent figure standing at -$130.7 million for Q2 2025.

  • On a quarterly basis, Interest Expenses fell 485455.24% year-over-year to -$130.7 million in Q2 2025; TTM through Dec 2025 was -$130.7 million, a 489223.09% decrease from a year earlier, with the FY2025 full-year figure at $252.5 million, up 165.75% from the prior year.
  • Interest Expenses retreated to -$130.7 million in Q2 2025 per IVA's latest filing, from -$26714.9 in the prior quarter.
  • Across five years, Interest Expenses topped out at -$14283.5 in Q4 2022 and bottomed at -$130.7 million in Q2 2025.
  • The 5-year median for Interest Expenses is -$38207.7 (2023), against an average of -$17.0 million.
  • Across the five-year window, Interest Expenses surged 46.02% in 2024 and plunged 485455.24% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at -$2.6 million in 2021, then soared by 99.46% to -$14283.5 in 2022, then tumbled by 246.51% to -$49493.2 in 2023, then surged by 46.02% to -$26714.9 in 2024, then tumbled by 489223.09% to -$130.7 million in 2025.
  • Per Business Quant, the three latest IVA Interest Expenses figures stand at -$130.7 million (Q2 2025), -$26714.9 (Q4 2024), and -$26922.2 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Inventiva 842.48 Mn 842.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -130.72 Mn
Jun 30, 2025 -130.72 Mn
Dec 31, 2024 -26,714.89
Dec 31, 2024 -26,714.89
Jun 30, 2024 -26,922.19
Jun 30, 2024 -26,922.19
Dec 31, 2023 -49,493.24
Dec 31, 2023 -49,493.24
Jun 30, 2023 -25,045.26
Jun 30, 2023 -25,045.26
Dec 31, 2022 -14,283.46
Dec 31, 2022 -14,283.46
Jun 30, 2021 -2.64 Mn
Jun 30, 2021 -2.64 Mn
Mar 31, 2021 -2.71 Mn
Mar 31, 2021 -2.71 Mn
Jun 30, 2020 -30,840.88
Jun 30, 2020 -30,840.88
Mar 31, 2020 -14,351.21
Mar 31, 2020 -14,351.21